You are here
EXPIRY OF SUBSCRIPTION PERIOD AND LAST TRADING DAY FOR SUBSCRIPTION RIGHTS IN THE RIGHTS ISSUE
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES
Reference is made to the announcement made by NorDiag ASA (the "Company") 18 November 2011. The subscription period, and the period for trading in subscription rights (NORD T), in connection with the Company's rights issue expires at 17:30 (CET) today, 2 December 2011.
Any subscription rights (whether granted or acquired) that are not sold, or used to subscribe for new shares in the rights issue prior to 17:30 (CET) on 2 December 2011, will lapse without compensation to the holder and cease to carry any value.
Holders of subscription rights (whether granted or acquired) must, in order to subscribe for new shares, submit a correctly completed subscription form by fax to DBN Markets, Registrars Department (fax no. +47 22 48 29 80).
Subscribers who are Norwegian citizens may also subscribe for shares through the VPS online subscription system or by following the link on www.nordiag.com or www.dnb.no/emisjoner, which will direct the subscriber to the VPS online system.
Please refer to the prospectus dated 17 November 2011 for more information.
For further information, please contact:
CEO Mårten Wigstøl, Phone: +47 911 65775
CFO Tone Kvåle, Phone: +47 915 19576
About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and reagents) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The Company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The Company has offices and laboratories in Stockholm, Sweden and in Atlanta (GA), USA. The group has today 31.6 man-labour years. NorDiag is listed on the Oslo Stock Exchange with ticker NORD.
For further information - www.nordiag.com.
Read the notice in Norwegian here.